|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$71,029.00 |
2.15% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,869.59 |
2.14% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$70,834.50 |
2.14% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$70,418.88 |
2.13% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$70,171.45 |
2.12% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$69,722.56 |
2.11% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$69,722.40 |
2.11% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$69,773.98 |
2.11% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$69,700.75 |
2.11% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$69,560.21 |
2.10% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$69,460.61 |
2.10% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$69,628.02 |
2.10% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$69,225.00 |
2.09% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$69,190.03 |
2.09% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$69,331.30 |
2.09% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$69,098.12 |
2.09% |
| Waters Corporation |
WAT |
941848103 |
147 |
$68,876.85 |
2.08% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$68,971.08 |
2.08% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$68,509.50 |
2.07% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$68,557.49 |
2.07% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$68,073.60 |
2.06% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$68,205.82 |
2.06% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$68,074.46 |
2.06% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,261.41 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
298 |
$68,090.02 |
2.06% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$67,870.44 |
2.05% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$67,925.85 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$67,764.88 |
2.05% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$67,454.82 |
2.04% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$67,512.00 |
2.04% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$67,325.40 |
2.03% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$67,327.88 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$67,278.06 |
2.03% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$67,171.90 |
2.03% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$67,355.10 |
2.03% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,222.94 |
2.03% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$66,558.75 |
2.01% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$66,673.25 |
2.01% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$66,445.47 |
2.01% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$66,190.20 |
2.00% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$66,194.93 |
2.00% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$65,789.33 |
1.99% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$65,464.84 |
1.98% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$65,455.43 |
1.98% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,808.00 |
1.96% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$59,705.60 |
1.80% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$56,237.76 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,849.28 |
1.69% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,548.27 |
1.35% |
| US Dollar |
$USD |
|
24,433 |
$24,433.37 |
0.74% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|